Andrew Cooper

Q: How accurate are Andrew Cooper's stock ratings?

About 77% of Andrew's ratings were profitable over a one-year hold, with an average return of +13.0% per rating, measured by 13Foresight from historical prices.

Q: How is Andrew ranked?

Andrew Cooper is ranked #804 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Raymond James

Wall Street Analyst

★★★★☆

#804

on 13Foresight · ranked by our own returns

77%

Success Rate

+13.4%

Average Return

24 of 31 calls profitable · +41.9% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

🔒 5-year track record is Pro. Showing 1-year — upgrade.

📈 Across the calls we could measure, roughly 77% of Andrew Cooper's ratings turned a profit when each position was held for 1 year — averaging +13.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

12 Buy 4 Hold 1 Sell

Andrew's Stock Coverage 27 ratings · 2026-11-10

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
EHC Encompass Health	Sep 28, 2026	BUY	Strong Buy -11.5% avg upside 23 analysts	$150.00 10.47% Upside	+11.1%	·
AVAH Aveanna Healthcare Holdings	Sep 28, 2026	BUY	Buy -13.4% avg upside 19 analysts	$15.00 13.89% Upside	+4.0%	·
THC Tenet Healthcare	Sep 28, 2026	BUY	Strong Buy -9.6% avg upside 29 analysts	$285.00 4.32% Upside	+11.1%	·
ACHC Acadia Healthcare	Sep 28, 2026	BUY	Strong Buy +49.8% avg upside 18 analysts	$39.00 30.21% Upside	+37.6%	·
HCA HCA Healthcare	Sep 28, 2026	HOLD	Strong Buy -11.8% avg upside 37 analysts	—	+16.9%	·
CYH Community Health	Sep 28, 2026	SELL	Sell +66.3% avg upside 20 analysts	—	+24.2%	·
HAE Haemonetics	Sep 03, 2026	BUY	Buy -20.9% avg upside 18 analysts	$125.00 4.48% Upside	+16.6%	·
ITGR Integer Holdings	Aug 03, 2026	HOLD	Buy -18.9% avg upside 16 analysts	—	+1.7%	·
GH Guardant Health	Feb 23, 2026	BUY	Strong Buy -3.1% avg upside 33 analysts	$129.00 27.77% Downside	+65.4%	·
MYGN Myriad Genetics	Jan 13, 2026	BUY	Sell +159.8% avg upside 24 analysts	$8.00 26.03% Upside	-4.5%	·
AZTA Azenta	Nov 25, 2025	BUY	Buy +24.4% avg upside 13 analysts	$45.00 15.12% Upside	+2.8%	·
AVTR Avantor	Nov 04, 2025	HOLD	Buy +4.5% avg upside 27 analysts	—	+35.1%	·
RVTY Revvity	Oct 28, 2025	BUY	Buy -19.9% avg upside 25 analysts	$115.00 26.84% Downside	+71.8%	·
QDEL QuidelOrtho	Aug 06, 2025	BUY	Strong Buy +195.9% avg upside 13 analysts	$55.00 315.17% Upside	-30.4%	·
FLGT Fulgent Genetics	Aug 04, 2025	BUY	Buy +115.0% avg upside 7 analysts	$25.00 21.26% Upside	+1.0%	·
TMO Thermo Fisher	Jul 24, 2025	BUY	Strong Buy -5.1% avg upside 40 analysts	$535.00 23.24% Downside	+20.1%	·
DHR Danaher	Jul 23, 2025	HOLD	Strong Buy -4.4% avg upside 47 analysts	—	-2.0%	·
UFPT Ufp Technologies	Mar 28, 2025	HOLD	Strong Buy -33.4% avg upside 7 analysts	—	-5.0%	·
NEO NeoGenomics	Feb 18, 2025	HOLD	Strong Buy +19.0% avg upside 19 analysts	—	-17.3%	·
NTRA Natera	Feb 10, 2025	BUY	Strong Buy -13.3% avg upside 28 analysts	$175.00 57.78% Downside	+22.9%	·
CDNA CareDx	May 13, 2024	HOLD	Buy -41.1% avg upside 18 analysts	—	+7.7%	·
CTKB Cytek Biosciences	Jul 18, 2023	HOLD	Buy -4.2% avg upside 5 analysts	—	-29.1%	·
VCYT Veracyte	Feb 22, 2023	HOLD	Strong Buy +4.5% avg upside 19 analysts	—	+1.8%	·
OSUR Orasure Technologies	Feb 15, 2023	HOLD	Buy +111.5% avg upside 12 analysts	—	+24.6%	·
BIORQ Biora Therapeutics	Feb 24, 2022	BUY	Buy +22439999900.0% avg upside 7 analysts	$1050.00 104999999899.97% Upside	·	·
TRUP Trupanion	Feb 11, 2021	HOLD	Strong Buy +29.9% avg upside 19 analysts	—	-14.9%	·
IDXX Idexx Laboratories	Feb 02, 2021	HOLD	Buy +30.3% avg upside 19 analysts	—	+5.4%	·

🔒 22 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Andrew Cooper — Frequently Asked Questions

How accurate are Andrew Cooper's stock ratings?

Based on the calls 13Foresight could measure, about 77% of Andrew's ratings were profitable over a one-year hold, with an average return of +13.0% per rating, or +41.4% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Andrew ranked on 13Foresight?

Andrew Cooper is currently ranked #804 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Andrew cover?

Andrew most recently has ratings on EHC, AVAH, THC, ACHC, HCA, CYH, HAE, ITGR, GH, MYGN, AZTA, AVTR and 15 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Andrew Cooper

Rating Distribution

Welcome to 13Foresight!